(0.11%) 5 137.25 points
(0.08%) 38 473 points
(0.17%) 17 875 points
(-0.30%) $83.60
(1.35%) $1.949
(0.29%) $2 353.90
(0.54%) $27.69
(1.58%) $936.65
(-0.16%) $0.933
(-0.34%) $10.99
(-0.28%) $0.798
(1.23%) $93.00
Q4/2023
Generated By Getagraph.com: 2023-12-31
IDEXX Laboratories Inc [IDXX]
2.06% $ 499.30
Exchange: NASDAQ Sector: Healthcare Industry: Diagnostics & Research
The financial report for IDXX (IDEXX Laboratories, Inc.) for the fourth quarter of 2023 (Q4 2023) shows a total revenue of $901.6 million, with a gross profit of $526.2 million. The net income for this period was $194.5 million, resulting in an EPS of $2.34. The company's total assets were valued at $3.26 billion, with total liabilities of $1.78 billion and total stockholders' equity of $1.48 billion. The report also includes a detailed breakdown of the company's financial performance, including operating expenses, cash flow, and balance sheet.
The total revenue for Q4 2023 was $901.6 million, with a gross profit ratio of 58.36%. However, the company incurred operating expenses of $280.9 million, resulting in an operating income of $245.3 million. The income before tax was $239.7 million, with a net income ratio of 21.58%.
To visualize the revenue and cost breakdown, the following interactive chart is generated using echarts.js:
IDXX had total assets of $3.26 billion, with the majority of assets in the form of other non-current assets ($1.06 billion) and property, plant, and equipment net ($702.18 million). The company's total liabilities were $1.78 billion, with current liabilities accounting for $951.55 million and non-current liabilities totaling $823.85 million. The total stockholders' equity was $1.48 billion, accounting for 45.46% of the company's total assets.
Unfortunately, the provided data does not include specifics about the company's cash flow for Q4 2023. Therefore, detailed analysis of the company's cash flow for this period is not available.
IDEXX Laboratories, Inc. displayed a solid financial performance in Q4 2023, with strong revenues and profitability. The company also maintains a healthy balance sheet with a favorable asset-to-liability ratio. However, more detailed information on the company's cash flow for this period would provide a more comprehensive analysis of its overall financial health.
IDXX Reports Strong Revenue and Profitability for Q4 2023
Metric | Value |
---|---|
Total Revenue | $901.6M |
Gross Profit | $526.2M |
Operating Income | $245.3M |
Net Income | $194.5M |
EPS | $2.34 |
Total Assets | $3.26B |
Total Liabilities | $1.78B |
Total Stockholders' Equity | $1.48B |
Financial Revenue: Link
Financial Cash Flow: Link
Financial Balance: Link
Revenues Q4 - 2023
Revenue | Gross Profit | Operating Expenses | Interest Expense | EBITDA | Net Income | EPS |
---|---|---|---|---|---|---|
$901.60M | $526.17M" | $280.87M | $-5.63M | $245.30M | $194.52M | $2.34 |
Balance Q4 - 2023
Net Income | Depreciation and Amortization | Stock Based Compensation | Change in Working Capital | Net Cash Provided by Operating Activities | Capital Expenditure | Free Cash Flow |
---|---|---|---|---|---|---|
$194.52M | $29.74M | $15.22M | $41.82M | $249.85M | $-32.56M | $217.30M |